ARCHIVES

In Brief: Caplan Receives NSB Public Service Award

This article is from The Cancer Letter archive.

Vol. 40 No. 13 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

IOM Selects Advisors To Defense Department

February 5, 1993

Minority Professional Training Concept Gets Approval Of NCAB

March 1, 1991